Literature DB >> 15289025

Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.

Andrew S Daly1, Suzanne Kamel-Reid, Jeffrey H Lipton, Hans A Messner, Thomas L Kiss, Kathy Chun, Lambert Busque, Hong Chang.   

Abstract

We report a patient with PML/RARalpha-positive acute promyelocytic leukemia (APL) who developed PML/RARalpha-negative acute myeloid leukemia 37 months after allogeneic bone marrow (BMT) transplant for molecular relapse. Features of myelodysplasia were noted 11 months earlier, chimerism testing by analysis of short tandem repeats was consistent with development of myelodysplasia and acute leukemia within cells of donor origin. To our knowledge, this is the first report of donor cell leukemia following BMT for APL. We hypothesize that replicative stress may lead to the development of some cases of donor cell acute leukemia.

Entities:  

Mesh：

Year:  2004        PMID： 15289025     DOI： 10.1016/j.leukres.2004.02.003

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  8 in total

1.  Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

Authors:  Nirali N Shah; Ulrike Bacher; Terry Fry; Katherine R Calvo; Maryalice Stetler-Stevenson; Diane C Arthur; Roger Kurlander; Kristin Baird; Barbara Wise; Sergio Giralt; Michael Bishop; Nancy M Hardy; Alan S Wayne
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

Review 2.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

3.  An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells?

Authors:  S Bigliardi; M Morselli; L Potenza; P Bresciani; A Cuoghi; V Coluccio; G Riva; A Paolini; V Fantuzzi; L Faglioni; V Nasillo; A Messerotti; R Marasca; F Narni; M Luppi; F Forghieri
Journal:  Bone Marrow Transplant       Date:  2014-06-02       Impact factor: 5.483

4.  A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation.

Authors:  Seong Hyun Jeong; Jae Ho Han; Seon Yong Jeong; Seok Yun Kang; Hyun Woo Lee; Jin-Hyuk Choi; Joon Seong Park
Journal:  Korean J Hematol       Date:  2010-03-31

Review 5.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

Review 6.  Chloroma of pancreas-initial manifestation of a secondary leukemia after stem cell transplantation case report and review of the literature.

Authors:  Navid Tabriz; Andrea Tannapfel; Frank Griesinger; Dirk Weyhe
Journal:  J Gastrointest Surg       Date:  2013-02-16       Impact factor: 3.452

7.  Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients.

Authors:  E G Baraban; S Hu; P Hui; N Podoltsev; D Cooper; M L Xu
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

Review 8.  Risks and mechanisms of oncological disease following stem cell transplantation.

Authors:  Sergey V Anisimov; Asuka Morizane; Ana S Correia
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.